Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligodendrogliomas

K Peterson1, J G Cairncross

  • 1Department of Neurology, University of Minnesota, Minneapolis, USA.

Neurologic Clinics
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Oligodendrogliomas are brain tumors that can be slow-growing or aggressive. Treatment varies based on tumor type, with conservative approaches for non-malignant types and advanced therapies for aggressive or recurring oligodendrogliomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same author

Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide.

CellR4-- repair, replacement, regeneration, & reprogramming·2019
Same author

Trends in diagnoses after implementation of the Chicago classification for esophageal motility disorders (V3.0) for high-resolution manometry studies.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.

Cell proliferation·2016
Same author

Peroneal Nerve Palsy After Cryotherapy.

The Physician and sportsmedicine·2016
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Pathology

Background:

  • Oligodendrogliomas represent a significant category of primary brain tumors.
  • These tumors exhibit a spectrum of clinical behaviors, ranging from indolent to highly malignant.
  • Histologic features are crucial in predicting tumor behavior and patient prognosis.

Purpose of the Study:

  • To review the current understanding of oligodendroglioma behavior.
  • To discuss the evolving treatment strategies for oligodendrogliomas.
  • To highlight the importance of histologic classification in guiding therapeutic decisions.

Main Methods:

  • Literature review of oligodendroglioma studies.
  • Analysis of treatment outcomes based on tumor grade.

Related Experiment Videos

  • Synthesis of current therapeutic guidelines and emerging therapies.

    • Main Results:

    • Many oligodendrogliomas are slow-growing with prolonged survival.
    • Aggressive or malignant oligodendrogliomas exhibit distinct histologic characteristics.
    • Treatment paradigms are shifting towards tailored approaches based on tumor aggressiveness.

    Conclusions:

    • Oligodendroglioma management requires careful consideration of tumor biology.
    • Conservative management remains appropriate for select non-anaplastic tumors.
    • Advanced systemic therapies are increasingly vital for managing aggressive and recurrent oligodendrogliomas.